The accompanying notes are an integral part of these consolidated
financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
The accompanying notes are an integral part of these consolidated financial statements.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
(UNAUDITED)
NOTE 1 – NATURE OF OPERATIONS
Our consolidated financial statements include
the accounts of Zurvita Holdings, Inc. (referred to herein as the “Company,” “Zurvita Holdings,” “we,”
“us” or “our”) and our wholly-owned subsidiary Zurvita, Inc. (Zurvita). Material intercompany transactions
and balances have been eliminated upon consolidation. Zurvita Holdings is a national network marketing company offering high-quality
products targeting individuals and families with a strong foothold in small town America and expanding into national urban centers.
Products are sold through Zurvita’s network of independent sales consultants.
Management’s Assessment of Liquidity
Since the Company’s inception, the Company
has primarily met its operating cash requirements through equity contributions from The Amacore Group, Inc. (Amacore), who was
the Company’s sole shareholder prior to July 30, 2009. Subsequent to July 30, 2009, the Company has sold several series of
preferred stock for gross proceeds of $6.8 million to another related party. We are using the proceeds from the sale of preferred
stock to subsidize the Company’s operations as the Company’s revenues and operating cash flows are not currently sufficient
to support the Company’s current operations.
At October 31, 2012, the Company had negative
working capital of approximately $942 thousand, an accumulated deficit of approximately $20.2 million and positive cash flows from
operating activities of approximately $200 thousand. Since the date of inception, the Company has used approximately $9.9 million
in operations.
Additional cash resources may be required should
the Company not meet its sales targets, exceed its projected operating costs, wish to accelerate sales or complete one or more
acquisitions or if unanticipated expenses arise or are incurred.
The Company does not currently maintain a line
of credit or term loan with any commercial bank or other financial institution and has not made any other arrangements to obtain
additional financing. We can provide no assurance that we will not require additional financing. Likewise,
we can provide no assurance that if we need additional financing that it will be available in an amount or on terms acceptable
to us, if at all. If we are unable to obtain additional funds when they are needed or if such funds cannot be obtained
on terms favorable to us, we may be unable to execute our business plan or pay our costs and expenses as they are incurred, which
could have a material, adverse effect on our business, financial condition and results of operations.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Revenue Recognition
Administrative Websites
Company’s independent representatives
pay a fee to the Company entitling them to use of websites that facilitate their business operations. Revenue is recognized
ratably over the website subscription period.
Advertising Sales
The Company markets subscriptions to a service
that facilitates the ability of customers, typically small business owners, to display commercial advertising via an on-line search
directory. Revenue is recognized ratably over the advertising subscription period.
Commissions
The Company is paid a commission for its sales
of third-party products. Commissions are recognized as products are sold and services performed and the Company has accomplished
all activities necessary to complete the earnings process.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
Consumable Products
The Company markets a line of nutritional drinks
under the “Zeal” umbrella. Revenue from the sale of these consumable products is recognized upon shipment of the product.
Marketing Fees and Materials
The Company also earns ancillary revenue from
the sale of marketing materials to sales consultants. Revenue is recognized when marketing materials are delivered.
Membership Fees
The Company recognizes revenues from membership
fees as earned for the sales of other lifestyle discount benefit programs, such as household protection and personal financial
services. These arrangements are generally renewable monthly and revenue is recognized over the renewal period.
Refunds and Chargebacks
The Company records a reduction in revenue
for estimated refunds and chargebacks from credit card companies based upon actual history and management’s evaluation of
current facts and circumstances. Refunds and chargebacks totaled approximately $39 thousand and $13 thousand for the
three months ended October 31, 2012 and 2011, respectively, and were recorded as a reduction of revenue in the accompanying statements
of operations. Estimates for an allowance for refunds and chargebacks totaling approximately $10 thousand is included
in accrued expenses in the accompanying consolidated balance sheets as of October 31, 2012 and July 31, 2012, respectively.
Selling and Marketing Costs
The Company classifies merchant account fees,
fulfillment costs and lead cost not identifiable with specific product sales within selling and marketing costs within the Statement
of Operations.
Concentration of Credit Risk
All of the Company’s credit card processing
is with one merchant processor, as well as all marketing sales commission payments are calculated by a third-party service provider.
Use of Estimates
The preparation of these consolidated
financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues
and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including
the allowance for sales refunds and chargebacks, capitalization of certain assets, depreciable/amortizable lives, impairment of long-lived
assets, determination of amount of allowance for doubtful accounts, the fair value of marketable securities, the expected volatility
of common stock, and the fair value of common stock and warrants as well as the allocation of proceeds from the issuance of debt
and equity instruments. We base our estimates on historical experience and on various other assumptions that we believe
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of
assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under
different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are
reasonable.
Accounts Receivable
Accounts receivable are stated at estimated
net realizable value. Accounts receivable are primarily comprised of balances due from memberships, net of estimated allowances
for uncollectible accounts. In determining collectability, historical trends are evaluated and specific customer issues are reviewed
to arrive at appropriate allowances. At October 31, 2012 and July 31, 2012, no allowance was deemed necessary therefore none was
recorded.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
Property, Plant and Equipment
Property, plant and equipment are recorded
at cost. The cost of additions and improvements are capitalized, while maintenance and repairs are charged to expense as incurred.
The Company provides for depreciation and amortization using the straight-line method over the estimated useful lives of the property
as follows: computer hardware, 3 years; furniture and fixtures, 7 years; equipment and machinery, 5 years; and leasehold improvements,
the shorter of the term of the lease or the life of the asset. When assets are retired or otherwise disposed of, the assets and
related accumulated depreciation are eliminated from the accounts and the resulting gain or loss is reflected in the results of
operations.
Share-Based Compensation
The
fair value of each stock option award is estimated on the date of grant using the Black-Scholes option valuation model. The Black-Scholes
option valuation model incorporates assumptions as to dividend yield, volatility, an appropriate risk-free interest rate and the
expected life of the option. Many of these assumptions require management’s judgment. The Company’s stock volatility
assumption is based upon its historical stock price fluctuations. The Company uses historical data to estimate option forfeiture
rates and the expected term of options granted. The risk-free rate for periods within the contractual life of the option is based
on the U.S. Treasury yield curve at the time of grant.
Convertible Instruments
The Company reviews the terms of convertible
debt and preferred stock for indications requiring bifurcation, and separate accounting for the embedded conversion feature. Generally,
embedded conversion features where the ability to physical or net-share settle the conversion option is not within the control
of the Company or the number of shares is variable are bifurcated and accounted for as derivative financial instruments. (See
Derivative
Financial Instruments
below.) Bifurcation of the embedded derivative instrument requires allocation of the proceeds first to
the fair value of the embedded derivative instrument with the residual allocated to the host instrument. The resulting discount
to the debt instrument or to the redemption value of convertible preferred securities is accreted through periodic charges to interest
expense over the term of the note or to dividends over the period to earliest conversion date using the effective interest rate
method, respectively.
Derivative Financial Instruments
The Company does not use derivative financial
instruments to hedge exposures to cash-flow or market risks. However, certain other financial instruments, such as warrants to
purchase the Company’s common stock and the embedded conversion features of debt and preferred instruments that are not considered
indexed to the Company’s common stock are classified as liabilities when either (a) the holder possesses rights to net-cash
settlement, (b) physical or net share settlement is not within the control of the Company, or (c) based on its anti-dilutive provisions.
In such instances, net-cash settlement is assumed for financial accounting and reporting. Such financial instruments are initially
recorded at fair value and subsequently adjusted to fair value at the close of each reporting period. Fair value for option-based
derivative financial instruments is determined using the Black-Scholes Option Pricing Model.
Income Taxes
The Company accounts for income taxes using
an asset and liability method pursuant to which deferred tax assets and liabilities are recognized for future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to reverse. The effect on deferred tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided against
deferred tax assets based on the weight of available evidence when it is more likely than not that some or all of the deferred
tax assets will not be realized.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
When tax returns are filed, it is highly
certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to
uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The
benefit of a tax position is recognized in the financial statements in the period during which, based on all available
evidence, we believe it is more likely than not that the position will be sustained upon examination, including the
resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.
Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that
is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the
benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability
for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would
be payable to the taxing authorities upon examination. Interest and penalties associated with unrecognized tax benefits are
classified as income tax expense in the statement of operations.
Fair Value Measurements
U.S. GAAP defines fair value as the price that
would be received to sell an asset or paid to transfer a liability to a third party with the same credit standing (an exit price)
in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on
the measurement date. In many cases, the exit price and the transaction (or entry) price will be the same at initial recognition.
However, in certain cases, the transaction price may not represent fair value. Fair value is a market-based measurement determined
based on a hypothetical transaction at the measurement date, considered from the perspective of a market participant, not based
solely upon the perspective of the reporting entity. When quoted prices are not used to determine fair value, consideration is
given to three broad valuation techniques: (i) the market approach, (ii) the income approach, and (iii) the cost approach. Entities
are required to determine the most appropriate valuation technique to use, given what is being measured and the availability of
sufficient inputs. Inputs to fair valuation techniques are prioritized, allowing for the use of unobservable inputs to the extent
that observable inputs are not available. The applicable guidance establishes a three-level hierarchy, based on the priority of
the inputs to the respective valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active
markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An asset or liability’s
classification within the fair value hierarchy is based on the lowest level of significant input to its valuation. The input levels
are defined as follows:
Level 1
|
|
Unadjusted quoted prices in active markets for identical assets or liabilities.
|
Level 2
|
|
Quoted prices in markets that are not active or inputs that are observable either
directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities other than quoted prices in Level
1, quoted prices in markets that are not active, or other inputs that are observable or can be derived principally from or corroborated
by observable market data for substantially the full term of the assets or liabilities.
|
Level 3
|
|
Unobservable inputs that are supported by little or no market activity and are significant
to the fair value of the assets or liabilities. Unobservable inputs reflect the reporting entity’s own assumptions
about the assumptions that market participants would use in pricing the asset or liability. Level 3 assets and liabilities include
those whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as
those for which the determination of fair value requires significant management judgment or estimation.
|
Earnings
(Loss) Per Share
Basic earnings (loss) per share is calculated
by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding
for the period. Diluted earnings (loss) per share is calculated by dividing the net income (loss) by the weighted average number
of shares of common stock outstanding for the period, adjusted for the dilutive effect of common stock equivalents, using the treasury
stock method. Convertible debt and warrants, officer, employee and non-employee stock options that are considered potentially dilutive
are included in the fully diluted shares calculation as long as the effect is not anti-dilutive. Contingently issuable shares are
included in the computation of basic loss per share when the issuance of the shares is no longer contingent.
Subsequent Events
Management has evaluated subsequent events
through the date the financial statements were issued.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
NOTE 3 – NON CASH INVESTING AND FINANCING
ACTIVITIES
The following table presents a summary of the
various noncash investing and financing transactions that the Company entered into during the three months ended October 31,
|
|
2012
|
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financed insurance agreement
|
|
|
24,927
|
|
|
|
20,190
|
|
|
|
|
|
|
|
|
|
|
Interest converted to principal
|
|
|
–
|
|
|
|
34,080
|
|
NOTE 4 – NOTES PAYABLE
Notes payable consist of the following:
|
|
10/31/2012
(Unaudited)
|
|
|
7/31/2012
(Audited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing agreement; bearing interest at 4.65% per annum; payable in monthly installments of approximately $2.7 thousand due through Oct 2012
|
|
|
24,927
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Related party promissory notes payable; bearing interest of 10% per annum; unsecured; due on December 31, 2013
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
Related party promissory notes payable; bearing interest of 10% per annum; unsecured; due on December 31, 2013
|
|
|
600,000
|
|
|
|
600,000
|
|
|
|
|
|
|
|
|
|
|
Promissory note payable; bearing interest of 7.5% per annum; unsecured; principal payments due monthly approximately $27 thousand through July 2011; currently in default
|
|
|
158,127
|
|
|
|
158,127
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total notes payable
|
|
|
883,054
|
|
|
|
858,127
|
|
|
|
|
|
|
|
|
|
|
Less current portion
|
|
|
183,054
|
|
|
|
158,127
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
$
|
700,000
|
|
|
$
|
700,000
|
|
On April 20, 2012, the Company issued to Amacore
an on-demand promissory note for $200 thousand. The note accrued interest at 15% per annum. The Company repaid the note payable
plus accrued interest of $1 thousand.
On May 3, 2012, the Company issued to Mark
Jarvis a promissory note for $100 thousand. The note accrued interest at 10% per annum and is due on December 31, 2013. As of October
31, 2012, the Company has not repaid the note plus accrued interest of $3.8 thousand.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
On June 13, 2012, the Company issued to Vicis
Capital Managment an on-demand promissory note for $600 thousand. The note accrued interest at 10% per annum and is due December
31, 2013. As of October 31, 2012, the Company has not repaid the note plus accrued interest of $29.7 thousand.
The Company is in default with respect to the
promissory note due July 2011. Consequently, the Company has accrued interest in accordance with the promissory notes’ default
provision at an interest rate of 18%.
The following is a schedule of the future maturity
payments required under the Company’s promissory notes payable.
As of October 31, 2012
|
|
|
|
|
|
|
|
Current
|
|
|
$
|
183,054
|
|
|
2013
|
|
|
|
700,000
|
|
|
|
|
|
$
|
883,054
|
|
NOTE 5 - ACCRUED EXPENSES
Accrued expenses consist of the following at
October 31, 2012 and July 31, 2012:
|
|
|
|
|
|
|
|
|
10/31/2012
(Unaudited)
|
|
|
7/31/2012
(Audited)
|
|
Commissions
|
|
$
|
815,456
|
|
|
$
|
461,295
|
|
Interest
|
|
|
88,095
|
|
|
|
63,280
|
|
Payroll
|
|
|
110,261
|
|
|
|
74,202
|
|
Product
|
|
|
–
|
|
|
|
59,688
|
|
Refund reserve
|
|
|
10,000
|
|
|
|
10,000
|
|
Sales tax payable
|
|
|
132,645
|
|
|
|
93,544
|
|
Services
|
|
|
–
|
|
|
|
30,000
|
|
Unclaimed property
|
|
|
40,513
|
|
|
|
40,513
|
|
Finance agreement
|
|
|
–
|
|
|
|
4,722
|
|
Total
|
|
$
|
1,196,970
|
|
|
$
|
837,244
|
|
NOTE 6 - DEFERRED REVENUE
Deferred revenue consists of the following
at October 31, 2012 and July 31, 2012:
|
|
10/31/2012
(Unaudited)
|
|
|
7/31/2012
(Audited)
|
|
Advertising
|
|
$
|
1,000
|
|
|
$
|
3,261
|
|
Consumable products
|
|
|
86,184
|
|
|
|
47,030
|
|
Direct response media
|
|
|
24,939
|
|
|
|
24,939
|
|
Member fees
|
|
|
3,500
|
|
|
|
4,931
|
|
Total
|
|
$
|
115,623
|
|
|
$
|
80,161
|
|
NOTE 7 – ASSETS AND LIABILITIES MEASURED
AT FAIR VALUE
Financial instruments which are measured at
estimated fair value on a recurring basis in the consolidated financial statements include marketable securities, an embedded share
conversion feature and non-compensatory warrants. The fair value of the marketable securities was determined by the market price
as quoted on the OTC. The fair value of the share conversion feature and warrants was determined by an independent expert valuation
specialist using the Black-Scholes Option Pricing Model.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
Assets and liabilities measured at estimated
fair value and their corresponding fair value hierarchy is summarized as follows:
October 31, 2012
|
Fair Value Measurements at Reporting Date Using
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in Active Markets for Identical
Assets
|
|
|
|
Significant Unobservable Inputs
|
|
|
|
Total
|
|
|
|
|
(Level 1)
|
|
|
|
(Level 3)
|
|
|
|
Fair Value
|
|
Share conversion feature
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
|
–
|
|
|
|
399,748
|
|
|
|
399,748
|
|
Total liabilities
|
|
$
|
–
|
|
|
$
|
399,748
|
|
|
$
|
399,748
|
|
July 31, 2012
|
Fair Value Measurements at Reporting Date Using
|
(Audited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in Active Markets for Identical
Assets
|
|
|
|
Significant Unobservable Inputs
|
|
|
|
Total
|
|
|
|
|
(Level 1)
|
|
|
|
(Level 3)
|
|
|
|
Fair Value
|
|
Share conversion feature
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
|
–
|
|
|
|
262,800
|
|
|
|
262,800
|
|
Total liabilities
|
|
$
|
–
|
|
|
$
|
262,800
|
|
|
$
|
262,800
|
|
The Company has categorized its assets and
liabilities measured at fair value into the three-level fair value hierarchy, as defined in Note 2, based upon the priority of
inputs to respective valuation techniques. Assets included in the level 1 of the fair value hierarchy include marketable securities
which are fair valued on a recurring basis using quoted market prices. Liabilities included within level 3 of the fair value hierarchy
presented in the preceding table include a share conversion feature and noncompensatory warrants. The valuation methodology for
liabilities within level 3 uses a combination of observable and unobservable inputs in calculating fair value.
The Company recorded an unrealized loss of
$0 thousand and $33 thousand on its marketable securities for the three months ended October 31, 2012 and 2011, respectively. These
losses have been included in the Statement of Operations caption “Loss on change in fair value of marketable securities.”
The changes in level 3 liabilities measured
at fair value on a recurring basis during the three months ended October 31, 2012 and the year ended July 31, 2012 are summarized
as follows:
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
|
|
Balance
Beginning of
Period
|
|
|
Issuance
|
|
|
(Gain) Loss
Recognized in
Earnings from
Change in
Fair Value
|
|
|
Balance End
of Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Period Ended October 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share conversion feature
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
$
|
262,800
|
|
|
$
|
–
|
|
|
$
|
136,948
|
|
|
$
|
399,748
|
|
|
|
Balance
Beginning of
Period
|
|
|
Issuance
|
|
|
(Gain) Loss
Recognized in
Earnings from
Change in
Fair Value
|
|
|
Balance End
of Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended July 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share conversion feature
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants
|
|
$
|
299,600
|
|
|
$
|
–
|
|
|
$
|
(36,800
|
)
|
|
$
|
262,800
|
|
For the three months ended October 31, 2012
and 2011, an unrealized loss of $137 thousand and an unrealized gain of $228 thousand, respectively, are included in earnings within
the Statement of Operations caption “Gain on change in fair value of warrants.”
Fair Value of Financial Instruments
The fair values of accounts receivable, accounts
payable and accrued expenses approximate their carrying values due to the short term nature of these instruments. The fair values
of notes payable approximate their carrying amounts as interest rates on these obligations are representative of estimated market
rates available to the Company on similar instruments.
NOTE 8—REDEEMABLE PREFERRED STOCK
The Company is authorized to issue 11.35 million
shares of preferred stock with a par value of $0.0001 per share. The following table summarizes the Preferred Stock issuances and
number of Preferred Shares outstanding:
|
|
|
|
Shares Outstanding at
|
Preferred Stock
|
|
Date of
|
|
|
|
|
Issuance
|
|
Issuance
|
|
October 31, 2012
|
|
July 31, 2012
|
Series A
|
|
July 30, 2009
|
|
1,750,000
|
|
1,750,000
|
Series B
|
|
October 6, 2009
|
|
2,000,000
|
|
2,000,000
|
Series C
|
|
January 29, 2010
|
|
1,000,000
|
|
1,000,000
|
Series C
|
|
June 3, 2010
|
|
2,300,000
|
|
2,300,000
|
Series C
|
|
June 9, 2011
|
|
1,500,000
|
|
1,500,000
|
Series C
|
|
December 28, 2011
|
|
2,800,000
|
|
2,800,000
|
|
|
|
|
11,350,000
|
|
11,350,000
|
Series A, Series B and Series C Convertible
Preferred Stock is collectively referred to herein as “Convertible Preferred Stock.”
Significant rights of the Convertible Preferred
Stock are discussed below:
Dividends
The Convertible Preferred Stock does not accrue
dividends.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
Voting Rights
Each holder of the shares of Convertible Preferred
Stock shall have the right to the number of votes equal to the number of Conversion Shares then issuable upon conversion of the
Convertible Preferred Stock held by such holder in all matters as to which shareholders are required or permitted to vote, and
with respect to such vote, such holder shall have full voting rights and powers equal to the voting rights and powers of the holders
of Common Stock, and shall be entitled to vote, together with the holders of Common Stock as a single class, with respect to any
question upon which holders of Common Stock have the right to vote; provided, however, as to any holder of Convertible Preferred
Stock, the right to vote such shares shall be limited to the number of shares issuable to such holder pursuant to certain beneficial
ownership limitations (as listed below) as of the record date for such vote. To the extent permitted under applicable corporate
law, but subject to certain limitations on corporate actions as disclosed below, the Corporation’s shareholders may take
action by the affirmative vote of a majority of all shareholders of the Company entitled to vote on an action. Without limiting
the generality of the foregoing, the Company may take any of the actions by the affirmative vote of the holders of a majority of
the Convertible Preferred Stock and the Common Stock and other voting common stock equivalents, voting together as one class.
As long as any shares of Convertible Preferred
Stock are outstanding, the Company shall not, without the written consent or affirmative vote of the holders of no-less than 51
percent of the then outstanding stated value of the Convertible Preferred Stock consenting or voting as a separate class from the
common stock, the Company shall not, either directly or by amendment, merger, consolidation or otherwise:
(i)
amend
its certificate or articles of incorporation in any manner that adversely affects the rights of the holders of Convertible Preferred
Stock;
(ii)
alter
or change adversely the voting or other powers, preferences, rights, privileges, or restrictions of the Convertible Preferred Stock;
(iii)
increase
the authorized number of shares of preferred stock or Convertible Preferred Stock or reinstate or issue any other series
of preferred stock;
(iv)
redeem,
purchase or otherwise acquire directly or indirectly any junior securities or any shares pari passu with the Convertible Preferred
Stock;
(v)
directly
or indirectly pay or declare any dividend or make any distribution in respect of, any junior securities, or set aside any monies
for the purchase or redemption (through a sinking fund or otherwise) of any junior securities or any shares pari passu with the
Convertible Preferred Stock;
(vi)
authorize
or create any class of stock ranking as to dividends, redemption or distribution of assets upon a liquidation senior to or otherwise
pari passu with the Convertible Preferred Stock; or
(vii)
enter into any agreement with respect to any of the foregoing.
Liquidation Preferences
Upon any liquidation, dissolution or winding-down
of the Company, whether voluntary or involuntary (a “Liquidation”), the holders of the shares of Convertible Preferred
Stock shall be paid in cash, before any payment shall be paid to the holders of common stock, or any other junior stock, an amount
for each share of Convertible Preferred Stock held by such holder equal to the sum of the Stated Value thereof (such applicable
amount payable with respect to a share of Convertible Preferred Stock sometimes being referred to as the “Individual Preferred
Liquidation Preference Payment” and with respect to all shares of Convertible Preferred Stock in the aggregate sometimes
being referred to as the “Aggregate Liquidation Preference Payment”). If, upon such liquidation, dissolution
or winding-up of the Company, whether voluntary or involuntary, the assets to be distributed among the holders of shares of Convertible
Preferred Stock shall be insufficient to permit payment to the holders of Convertible Preferred Stock of an aggregate amount equal
to the Aggregate Liquidation Preference Payment, then the entire assets of the Corporation to be so distributed shall be distributed
ratably among the holders of Convertible Preferred Stock (based on the Individual Preferred Liquidation Preference Payments due
to the respective holders of Convertible Preferred Stock).
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
The liquidation value of Series A, Series B
and Series C Convertible Preferred Stock was $1.75 million, $2 million and $4.8 million, respectively, as of October 31, 2012.
Conversion Rights
Each share of Convertible Preferred Stock shall
be convertible, at the option of the holder thereof, at any time after the original issue date (subject to beneficial ownership
limitations as listed below), and without the payment of additional consideration by the holder thereof, into such number of fully-paid
and nonassessable shares of common stock as is determined by dividing the Stated Value per share, by the Conversion Price in effect
at the time of conversion. The Conversion Price originally
for Series A, B and C shall be $0.0625, $0.25 and $0.25, respectively;
provided, however, that the Conversion Price, and the rate at which shares of Convertible Preferred Stock may be converted into
shares of common stock, shall be subject to adjustment as a result of stock dividends, stock splits, and subsequent equity sales
at a price lower than the Convertible Preferred Stock’s Conversion Price. Shares of Convertible Preferred Stock converted
into common stock shall be canceled and shall not be reissued.
At October 31, 2012, Series A, Series B and
Series C Convertible Preferred Stock is convertible into 28 million, 8 million, 19.2 million, and 11.2 million common shares, respectively.
If the Convertible Preferred Stock had been converted as of October 31, 2012, the aggregate market price of the common shares for
Series A, Series B and Series C would have been approximately $980 thousand, $280 thousand, $672 thousand, and $392 thousand, respectively.
Beneficial Ownership Limitations
The Company shall not affect any conversion
of the Convertible Preferred Stock, and a holder shall not have the right to convert any portion of the Convertible Preferred Stock,
to the extent that, after giving effect to the conversion, such holder (together with such holder’s affiliates, and any other
person or entity acting as a group together with such holder or any of such holder’s affiliates) would beneficially own in
excess 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares
of common stock issuable upon conversion of Convertible Preferred Stock held by the applicable holder. The Beneficial
Ownership Limitation provisions may be waived by such holder, at the election of such holder, upon not less than sixty one (61)
days’ prior notice to the Company, to change the Beneficial Ownership Limitation to 9.99% of the number of shares of the
common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of Convertible
Preferred Stock held by the applicable holder and the provisions of this section shall continue to apply. Upon such
a change by a holder of the Beneficial Ownership Limitation from such 4.99% limitation to such 9.99% limitation, the Beneficial
Ownership Limitation shall not be further waived by such holder.
Redemption Rights of the Company
Shares of the Convertible Preferred Stock shall
be redeemable, in whole or in part, at the option of the Company, by resolution of its Board of Directors at any time after the
original issue date and before the first (1st) anniversary of the original issue date at a price equal to one hundred and ten percent
(110%) of the Stated Value.
Redemption Rights of Holder
The Convertible Preferred Stock is redeemable
for cash in an amount representing the Stated Value of outstanding Convertible Preferred Stock. The following events give rise
to a redemption triggering event:
|
·
|
The Company shall be party to a change
of control transaction;
|
|
·
|
The Company shall fail to have available
a sufficient number of authorized and unreserved shares of common stock to issue to such holder upon a conversion;
|
|
·
|
Unless specifically addressed elsewhere
in the Convertible Preferred Stock’s Certificate of Designation as a Triggering Event, the Corporation shall fail to observe
or perform any other covenant, agreement or warranty contained in the Certificate of Designation, and such failure or breach shall
not, if subject to the possibility of a cure by the Company, have been cured within 20 calendar days after the date on which written
notice of such failure or breach shall have been delivered;
|
|
·
|
There shall have occurred a bankruptcy
event or material monetary judgment;
|
If the Company fails to pay the redemption
amount as a result of a triggering event on the date it is due, interest will accrue at a rate equal to the lesser of 18% per
year, or the maximum rate permitted by applicable law, accruing daily from the date of the triggering event until the amount is
paid in full.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
Events that may result in the redemption for
cash of preferred stock, and that are not within a company’s control may require the preferred stock to be classified outside
of stockholders’ equity (in the mezzanine section). All of the above triggering events are presumed not to be within our
control. Accordingly, these instruments are recorded in our balance sheet in the caption Redeemable Preferred Stock, which is outside
of stockholders’ equity. Management estimates the probability of the triggering events to be remote due to the Company’s
affiliation with stockholders that represent a majority of the outstanding common and preferred stock. Therefore, the carrying
value of the preferred stock has not been increased to the full redemption value.
The reason the carrying value is not equal
to the redemption amount is due to the allocation of value to certain warrants issued in connection with the preferred stock. The
following table summarizes for each preferred stock issuance the value allocated to the warrants and preferred stock:
|
|
|
|
Total
|
|
|
Value
|
|
|
Preferred Stock
|
|
Preferred Stock
|
|
Date of
|
|
Proceeds
|
|
|
Allocated to
|
|
|
Carrying
|
|
Issuance
|
|
Issuance
|
|
Received
|
|
|
Warrants
|
|
|
Amount
|
|
Series A
|
|
July 30, 2009
|
|
$
|
1,750,000
|
|
|
$
|
539,000
|
|
|
$
|
1,211,000
|
|
Series B
|
|
October 6, 2009
|
|
|
2,000,000
|
|
|
|
930,838
|
|
|
|
1,069,162
|
|
Series C
|
|
January 29, 2010
|
|
|
1,000,000
|
|
|
|
431,415
|
|
|
|
568,585
|
|
Series C
|
|
June 3, 2010
|
|
|
2,300,000
|
|
|
|
598,000
|
|
|
|
1,702,000
|
|
Series C
|
|
June 9, 2011
|
|
|
1,500,000
|
|
|
|
24,000
|
|
|
|
1,476,000
|
|
Series C
|
|
December 28, 2011
|
|
|
2,800,000
|
|
|
|
1,456
|
|
|
|
2,798,544
|
|
Total
|
|
|
|
$
|
11,350,000
|
|
|
$
|
2,524,709
|
|
|
$
|
8,825,291
|
|
NOTE 9 - COMMON STOCK
The Company has authorized 300 million common
shares with a par value of $0.0001 per share. On all matters required by law to be submitted to a vote of the holders of common
stock, each share of common stock is entitled to one vote per share.
On July 30, 2009, the Company granted Mr. Jarvis
1.8 million shares of common stock, to be held in escrow, in connection with the execution of an employment agreement. These shares
will be issued to Mr. Jarvis in accordance with the vesting period or upon completion of certain performance measures. Due to the
forward stock split, the amount of shares was increased to 7.2 million shares of common stock. The shares were subject to a vesting
period in which 3.6 million shares vested on July 30, 2010 and July 30, 2011, respectively. The grant date fair value was approximately
$306 thousand. As of October 31, 2011, all shares were vested and issued.
For the three months ended October 31, 2012
and 2011, approximately zero and $29 thousand, respectively, of stock-based compensation expense was recognized, as a result of
various share issuances.
On July 31, 2009, the Company entered into
a stock repurchase agreement with a majority shareholder to purchase 8 million shares for $210 thousand or $0.26 per share. The
treasury stock was recorded at cost. Management’s plan is to retain these shares.
On May 8, 2012, the Company and Amacore entered
into a Stock Purchase Agreement (the “Amacore Purchase Agreement”) whereby the Company purchased 37.21 million shares
of the Company’s common stock from Amacore. Pursuant to the Amacore Purchase Agreement, the Company paid to Amacore a purchase
price equal to $300 thousand. The treasury stock was recorded at cost.
On May 8, 2012, the Company and Infusion entered
into a Stock Purchase Agreement (the “Infusion Purchase Agreement”) whereby the Company purchased 15.2 million shares
of the Company’s common stock from Infusion. Pursuant to the Infusion Purchase Agreement, the Company paid to Infusion a
purchase price equal to $100 thousand. The treasury stock was recorded at cost.
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
NOTE 10–WARRANTS
During 2009, Zurvita’s Board of Directors
adopted the 2009 Incentive Stock Plan (the 2009 Plan), pursuant to which we reserved for issuance 6 million shares of Zurvita common
stock to be used as awards to employees, directors, consultants, and other service providers. The purpose of the 2009 Plan is to
provide an incentive to attract and retain officers, consultants, advisors and employees whose services are considered valuable,
to encourage a sense of proprietorship and to stimulate an active interest of such persons into Zurvita’s development and
financial success. Under the 2009 Plan, Zurvita is authorized to issue incentive stock options intended to qualify under Section
422 of the Code, non-qualified stock options, stock appreciation rights, performance shares, restricted stock and long term incentive
awards. The 2009 Plan is administered by the Board’s designated Compensation Committee. As of October 31, 2011, approximately
5.4 million total options were issued under the 2009 Plan.
The following table summarizes the status of
all warrants outstanding and exercisable at October 31, 2012.
Outstanding Warrants
|
|
Range of
Exercise Prices
|
|
Number of
Warrants
|
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted Average Remaining Contractual Life in Years
|
|
$0.06 to $0.49
|
|
|
71,908,000
|
|
|
$
|
0.17
|
|
|
|
4.36
|
|
$0.50 to $0.99
|
|
|
100,000
|
|
|
$
|
0.75
|
|
|
|
2.28
|
|
|
|
|
72,008,000
|
|
|
$
|
0.17
|
|
|
|
4.36
|
|
Exercisable Warrants
|
|
Range of
Exercise Prices
|
|
Number of
Warrants
|
|
|
Weighted
Average
Exercise Price
|
|
|
Weighted Average Remaining Contractual Life in Years
|
|
$0.06 to $0.49
|
|
|
71,908,000
|
|
|
$
|
0.17
|
|
|
|
4.36
|
|
$0.50 to $0.99
|
|
|
100,000
|
|
|
$
|
0.75
|
|
|
|
2.28
|
|
|
|
|
72,008,000
|
|
|
$
|
0.17
|
|
|
|
4.36
|
|
Compensatory Equity Warrants
During the three months ended October 31, 2012,
the Company issued compensatory equity warrants to purchase an aggregate of approximately 433 thousand shares of common stock.
Assumptions used to determine the fair value
of the compensatory warrants granted during the three months ended October 31, 2012 and during the year ended July 31, 2012 are
as follows.
|
|
October 31, 2012
|
|
July 31, 2012
|
Expected dividends
|
|
0%
|
|
0%
|
Expected volatility
|
|
71%
|
|
70%
|
Risk free interest rate
|
|
0.32% - 0.62%
|
|
0.25% - 0.94%
|
Expected life
|
|
5 years
|
|
5 years
|
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
The following table summarizes the activity
for compensatory warrants classified as equity for the three months ended October 31, 2012.
|
|
Compensatory Equity
Warrants
|
|
|
Weighted Average
Exercise Price
|
|
|
Weighted Average Remaining Contractual
Term
|
|
|
Aggregate
Intrinsic
Value
|
|
Outstanding at July 31, 2012
|
|
|
5,608,000
|
|
|
$
|
0.22
|
|
|
|
3.00
|
|
|
$
|
–
|
|
Granted
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Exercised
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Cancelled or Expired
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
|
|
–
|
|
Outstanding at October 31, 2012
|
|
|
5,608,000
|
|
|
$
|
0.22
|
|
|
|
2.75
|
|
|
$
|
–
|
|
Exercisable at October 31, 2012
|
|
|
5,608,000
|
|
|
$
|
0.22
|
|
|
|
2.57
|
|
|
$
|
–
|
|
The total fair value of warrants vested during
the year ended October 31, 2012 was approximately $177 thousand. The weighted average grant date fair value of warrants granted
during the year ended July 31, 2012 and 2011 was $0 and $0, respectively.
A summary of the status of the Company's non-vested
compensatory equity warrants as of October 31, 2012, and the changes during the three months ended October 31, 2012, is presented
below.
|
|
Compensatory Warrants
|
|
|
Weighted Average Grant-Date Fair Value
|
|
Non-vested at July 31, 2012
|
|
|
37,500
|
|
|
$
|
0.003
|
|
Issued
|
|
|
–
|
|
|
|
–
|
|
Vested
|
|
|
(37,500
|
)
|
|
|
–
|
|
Exercised
|
|
|
–
|
|
|
|
–
|
|
Non-vested at October 31, 2012
|
|
|
–
|
|
|
$
|
–
|
|
Non-compensatory Liability Warrants
There were approximately 66.4 million non-compensatory
warrants outstanding as of October 31, 2012, all of which were classified as liabilities. These warrants are classified as liability
instruments as net share settlement is not considered within the Company’s control or certain exercise prices are not fixed
which has the potential to cause a variable number of shares and/or value exchange upon exercise.
The fair value of each option award classified
as a liability on the balance sheets is estimated on the date of the grant using the Black-Scholes Pricing Model and the assumptions
noted in the following table. The stock price used approximates the market price less a marketability discount of 30%. Expected
volatility was determined by independent valuation specialist. The risk-free rate for periods within the contractual life of the
option is based on the U.S. Treasury Strip yield curve in effect at the time of grant. The expected term of options granted represents
the period of time that options granted are expected to be outstanding.
Assumptions used to determine the fair value
of the non-compensatory warrants outstanding during the three months ended October 31, 2012 and granted at and during the year
ended July 31, 2012 are as follows.
|
|
October 31, 2012
|
|
July 31, 2012
|
Expected dividends
|
|
0%
|
|
0%
|
Expected volatility
|
|
71%
|
|
70%
|
Risk free interest rate
|
|
0.53% - 1.04%
|
|
0.69% - 1.28%
|
Expected life
|
|
7 years
|
|
7 years
|
ZURVITA HOLDINGS, INC.
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS- CONTINUED
(UNAUDITED)
There were no vested or non-vested compensatory
liability issuances, exercises or expirations during the three months ended October 31, 2012.
Stock-Based Compensation Expense
For the three months ended October 31,
2012 and 2011, the Company recognized stock-based compensation expense, including both expense related to compensatory warrants
and expense related to share awards, with the Statement of Operations as follows:
|
|
For the
Three Months Ended
October 31, 2012
|
|
|
For the
Three Months Ended
October 31, 2011
|
|
Payroll and employee benefits
|
|
$
|
–
|
|
|
$
|
29,725
|
|
Total
|
|
$
|
–
|
|
|
$
|
29,725
|
|
NOTE 11 - RELATED PARTY TRANSACTIONS
Commissions Paid
There are immediate family members of Mr. Jarvis,
who operate as independent sales consultants who were paid commission compensation which approximated $57 thousand, respectively,
for the three months ended October 31, 2012, and approximately $27 thousand, respectively, for the three months ended October 31,
2011. These payments were for work they performed on behalf of the Company.
Note Payable to Mark Jarvis
On July 19, 2011, the Company issued to Mark
Jarvis an on-demand promissory note for $20 thousand. The note accrued interest at 15% per annum. As of October 31, 2012, the Company
had repaid the note plus accrued interest of $99.
On June 13, 2012, the Company issued to Mark
Jarvis an on-demand promissory note for $100 thousand. The note accrued interest at 10% per annum. As of October 31, 2012, the
Company had not repaid the note plus accrued interest of $3.8 thousand.
Note Payable to Vicis Capital Management
On May 3, 2012, the Company issued to Vicis
Capital Management an on-demand promissory note for $600 thousand. The note accrued interest at 10% per annum. As of October 31,
2012 the Company had not repaid the note plus accrued interest of $29.7 thousand.